Clinical Trials Logo

Clinical Trial Summary

This study's primary goal is to compare the efficacy and safety of the novel advanced hemostatic device(AHD), Vi-Sealer, with conventional AHDs in laparoscopic total hysterectomy for patients with benign gynecologic neoplasm.


Clinical Trial Description

Vi-Sealer is a reusable advanced bipolar electrode with an interchangeable blade. This study evaluates the efficacy and safety of the Vi-Sealer by comparing it with other advanced hemostatic devices, such as Ligasure, Enseal, Thunderbeat, Harmonic scalpel, etc. The economic evaluation of the device compared with other disposable devices would also be conducted. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05629611
Study type Interventional
Source CHA University
Contact Hyun Park
Phone +82-031-780-5640
Email p06162006@cha.ac.kr
Status Recruiting
Phase N/A
Start date January 20, 2023
Completion date October 31, 2025

See also
  Status Clinical Trial Phase
Completed NCT05710601 - Effects of Tissue Sealers on Minor Laparoscopic Procedures Between Obstetrics and Gynecology Residents
Recruiting NCT03645304 - Postoperative Analgesic Efficacy of Continuous Wound Infusion After Laparoscopy N/A
Recruiting NCT03009604 - Does Simethicone Improve Operative Field in Gynecological Operations Phase 3
Completed NCT03548831 - Comparative Study of LAVH and Minilaparotomy Hysterectomy